Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3
- PMID: 21131975
- PMCID: PMC3049257
- DOI: 10.1038/ng.723
Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3
Abstract
We conducted a two-stage genome-wide association study of renal cell carcinoma (RCC) in 3,772 affected individuals (cases) and 8,505 controls of European background from 11 studies and followed up 6 SNPs in 3 replication studies of 2,198 cases and 4,918 controls. Two loci on the regions of 2p21 and 11q13.3 were associated with RCC susceptibility below genome-wide significance. Two correlated variants (r² = 0.99 in controls), rs11894252 (P = 1.8 × 10⁻⁸) and rs7579899 (P = 2.3 × 10⁻⁹), map to EPAS1 on 2p21, which encodes hypoxia-inducible-factor-2 alpha, a transcription factor previously implicated in RCC. The second locus, rs7105934, at 11q13.3, contains no characterized genes (P = 7.8 × 10⁻¹⁴). In addition, we observed a promising association on 12q24.31 for rs4765623, which maps to SCARB1, the scavenger receptor class B, member 1 gene (P = 2.6 × 10⁻⁸). Our study reports previously unidentified genomic regions associated with RCC risk that may lead to new etiological insights.
Figures
References
-
- Ferlay J, Bray F, Pisani P, Parkin DM. IARC CancerBase No. 5. version 2.0. Lyon: IARCPress; 2004. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide.
-
- Scelo G, Brennan P. The epidemiology of bladder and kidney cancer. Nat. Clin Pract. Urol. 2007;4:205–217. - PubMed
-
- McLaughlin JK, et al. A population--based case--control study of renal cell carcinoma. J. Natl. Cancer Inst. 1984;72:275–284. - PubMed
-
- Schlehofer B, et al. International renal-cell-cancer study. VI. the role of medical and family history. Int. J. Cancer. 1996;66:723–726. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
